A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria

Trial Profile

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs GKT 831 (Primary)
  • Indications Diabetic nephropathies
  • Focus Proof of concept; Therapeutic Use
  • Sponsors GenKyoTex
  • Most Recent Events

    • 09 Sep 2015 Primary endpoint (Albuminuria) has not been met, according to a Genkyotex media release.
    • 09 Sep 2015 Results published in a Genkyotex media release.
    • 29 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top